Introduction
Seborrheic dermatitis (SD) is associated with significant psychological distress, including elevated anxiety and depression and quality-of-life impairment [1]. Psychological stress is frequently reported by patients as a precipitating factor for flareups, with symptom intensity often worsening during stressful periods [2]. While difficulties in emotion regulation have been linked to stress-related inflammatory processes in SD [3], trait anger and anger expression remain understudied, despite evidence from other inflammatory skin diseases suggesting that maladaptive anger expression may exacerbate stress responses [4].
Findings on alexithymia in SD are also inconsistent, with some studies reporting elevated scores and others showing no difference compared with healthy controls [5,6]. To address these gaps, we examined multiple psychological dimensions, including emotion regulation, trait anger, anger expression, alexithymia, depression, and anxiety, in SD patients and healthy controls, aiming to clarify their associations with disease severity and inform integrated care strategies.
Findings
A total of 134 individuals participated, including 67 patients with SD consecutively recruited from the Bagcilar Training and Research Hospital Dermatology Clinic and 67 age- and sex-matched healthy controls. Patients were diagnosed by the same dermatologist, disease severity was assessed with the Seborrheic Dermatitis Area and Severity Index (SDASI), and both groups completed standardized questionnaires assessing anxiety, depression, stress, emotion regulation, trait anger, anger expression, and alexithymia. Groups were comparable in age and sex, but controls had significantly higher educational attainment, which was included as a covariate in subsequent analyses.
Mean disease severity in the patient group was 8.28 (standard deviation (SD)=2.30), with male patients reporting higher severity than females (P=0.02). As shown in Table 1, patients with SD reported significantly higher levels of alexithymia, anxiety, expressive suppression, and trait anger compared to controls. The difference in alexithymia remained significant after adjusting for education.
Subscale analyses indicated that difficulty identifying feelings (DIF) and externally oriented thinking (EOT) were elevated in patients even after controlling for education, whereas difficulty describing feelings (DDF) did not remain significant. In contrast, no significant group difference was observed for depression, stress, cognitive reappraisal, or anger expression subscales (anger-in, anger-out, anger-control).
Disease severity was positively correlated with several psychological variables, most strongly with anxiety (ρ=0.49, P<0.001) and trait anger (r=0.41, P<0.001), with additional associations observed for depression, stress, suppression, alexithymia, anger-in, anger-out, DIF, and DDF. A repeated measures ANOVA on anger expression indicated overall differences between anger-in, anger-out, and anger-control (P<0.001), but no significant group effect or interaction, suggesting that the pattern of anger expression did not differ between patients and controls.
Conclusion
SD patients demonstrated significantly higher levels of anxiety, trait anger, expressive suppression, and alexithymia compared to controls. Among these, anxiety and trait anger showed the strongest associations with disease severity. These findings emphasize the psychological burden of SD and suggest that maladaptive regulation strategies may contribute to symptom exacerbation.
Incorporating routine psychological assessment and supportive interventions into dermatological care may improve both clinical outcomes and quality of life for affected patients.